ATE343794T1 - Ph-abhängige polypeptidaggregation und verwendung davon - Google Patents

Ph-abhängige polypeptidaggregation und verwendung davon

Info

Publication number
ATE343794T1
ATE343794T1 AT04722562T AT04722562T ATE343794T1 AT E343794 T1 ATE343794 T1 AT E343794T1 AT 04722562 T AT04722562 T AT 04722562T AT 04722562 T AT04722562 T AT 04722562T AT E343794 T1 ATE343794 T1 AT E343794T1
Authority
AT
Austria
Prior art keywords
aggregation
proteins
dissociation
reversible
oligomerization
Prior art date
Application number
AT04722562T
Other languages
English (en)
Inventor
Ralph Zahn
Original Assignee
Eidgenoess Tech Hochschule
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eidgenoess Tech Hochschule filed Critical Eidgenoess Tech Hochschule
Application granted granted Critical
Publication of ATE343794T1 publication Critical patent/ATE343794T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04722562T 2003-03-25 2004-03-23 Ph-abhängige polypeptidaggregation und verwendung davon ATE343794T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/397,059 US20040192887A1 (en) 2003-03-25 2003-03-25 PH-dependent polypeptide aggregation and its use

Publications (1)

Publication Number Publication Date
ATE343794T1 true ATE343794T1 (de) 2006-11-15

Family

ID=32988937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04722562T ATE343794T1 (de) 2003-03-25 2004-03-23 Ph-abhängige polypeptidaggregation und verwendung davon

Country Status (11)

Country Link
US (1) US20040192887A1 (de)
EP (1) EP1606628B1 (de)
JP (1) JP4354956B2 (de)
CN (1) CN100595209C (de)
AT (1) ATE343794T1 (de)
AU (1) AU2004224157B2 (de)
CA (1) CA2519993C (de)
DE (1) DE602004002943T2 (de)
ES (1) ES2274439T3 (de)
NZ (1) NZ543111A (de)
WO (1) WO2004085464A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2267496C2 (ru) * 2004-01-15 2006-01-10 Сергей Иванович Черныш Противоопухолевые и антивирусные пептиды
CA2627621A1 (en) * 2005-10-28 2007-05-03 Alicon Ag Method for concentrating, purifying and removing prion protein
EA009555B1 (ru) * 2005-11-30 2008-02-28 Сергей Иванович Черныш Пептид, обладающий иммуномодулирующей активностью, и фармацевтическая композиция
US20120296067A1 (en) * 2010-02-03 2012-11-22 Prism BioLab Co., Ltd. Compound capable of binding to naturally occurring denatured protein, and method for screening for the compound
CN111171115B (zh) * 2020-01-06 2022-05-27 山东大学 一种通过调节酸碱度控制多肽晶体可逆组装的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
JP4233604B2 (ja) * 1991-12-03 2009-03-04 プロセリックス メディスンズ ディベロップメント リミテッド プリオンタンパク質のフラグメント
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
FR2801106B1 (fr) * 1999-11-12 2007-10-05 Commissariat Energie Atomique Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc
EP1272509A2 (de) * 2000-04-05 2003-01-08 V.I. Technologies, Inc. Peptidische bindstoffe für prione und verfahren zu deren verwendung
US20030022243A1 (en) * 2001-06-20 2003-01-30 Les Kondejewski Protein aggregation assays and uses thereof

Also Published As

Publication number Publication date
NZ543111A (en) 2007-03-30
JP2007523831A (ja) 2007-08-23
EP1606628B1 (de) 2006-10-25
WO2004085464A2 (en) 2004-10-07
ES2274439T3 (es) 2007-05-16
DE602004002943T2 (de) 2007-07-05
AU2004224157A1 (en) 2004-10-07
CN1764840A (zh) 2006-04-26
CN100595209C (zh) 2010-03-24
AU2004224157B2 (en) 2007-02-08
CA2519993A1 (en) 2004-10-07
CA2519993C (en) 2011-02-15
JP4354956B2 (ja) 2009-10-28
US20040192887A1 (en) 2004-09-30
DE602004002943D1 (de) 2006-12-07
WO2004085464A3 (en) 2004-11-11
EP1606628A2 (de) 2005-12-21

Similar Documents

Publication Publication Date Title
NO20000934D0 (no) Adipocyttspesifikke proteinhomologer
NO20031049D0 (no) Syntetiske erytropoese-stimulerende proteiner
DK1844150T3 (da) Rekombinant ekspression af proteiner i en to-kædet form med disulfidbroer
ATE257160T1 (de) Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde
EP2298331A3 (de) Verwendung von Transthyretinpeptid-/-proteinfusionen zur Erhöhung der Serumshalbwertszeit von pharmakologisch aktiven Peptiden/Proteinen
EA200700847A1 (ru) Материалы, связывающие прионные белки, и способы их применения
DE60325892D1 (de) Stellungs- und verwendungsverfahren
GEP20094629B (en) Nogo receptor binding protein
NO20063026L (no) Antistoffer
DE69834643D1 (de) Adipozyten-spezifische protein homologe
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE529441T1 (de) Expression von proteinen in e.coli
DE60310385D1 (de) Sekretion von proteinen mit mehreren disulfidbindungen in bakterien und verwendungen davon
WO2003065003A3 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
ATE307826T1 (de) Oligomere von konformationsbeschränkten, nicht- peptidischen di- oder tripeptid-mimetika, und ihre verwendung zur synthese von künstlichen polypeptiden und proteinen
ATE343794T1 (de) Ph-abhängige polypeptidaggregation und verwendung davon
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
WO2002048174A3 (en) Dimeric fluorescent polypeptides
ATE355302T1 (de) N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
BR112022005426A2 (pt) Polipeptídeos de fusão dap10/dap12
WO2005028664A3 (en) Modulation of programmed necrosis
DE60330680D1 (de) Transferrin-fusionsproteinbibliotheken
WO2003093305A3 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof
DE602004027039D1 (de) Cytokinpolypeptidvarianten
WO2003057708A3 (en) Fusion proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties